|
|
|
|
LEADER |
00000cam a2200000Ma 4500 |
001 |
SCIDIR_ocn648302964 |
003 |
OCoLC |
005 |
20231117044422.0 |
006 |
m o d |
007 |
cr cn||||||||| |
008 |
750720s2003 ne a ob 001 0 eng d |
010 |
|
|
|z 58012341
|
040 |
|
|
|a E7B
|b eng
|e pn
|c E7B
|d OCLCQ
|d OPELS
|d OCLCF
|d OCLCQ
|d DEBBG
|d D6H
|d LEAUB
|d UHL
|d SFB
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 1127210093
|
020 |
|
|
|z 9780120103379
|
020 |
|
|
|a 1281004626
|
020 |
|
|
|a 9781281004628
|
020 |
|
|
|a 9786611004620
|
020 |
|
|
|a 6611004629
|
020 |
|
|
|a 0080490263
|
020 |
|
|
|a 9780080490267
|
035 |
|
|
|a (OCoLC)648302964
|z (OCoLC)1127210093
|
050 |
|
4 |
|a RB1
|b .A237 2003eb
|
082 |
0 |
4 |
|a 616.0756
|
245 |
0 |
0 |
|a Advances in clinical chemistry.
|n Volume 37 /
|c edited by Herbert E. Spiegel.
|
260 |
|
|
|a Amsterdam :
|b Academic Press,
|c 2003.
|
300 |
|
|
|a 1 online resource (xiii, 364 pages) :
|b illustrations.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Advances in clinical chemistry ;
|v v.37
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
520 |
|
|
|a This volume, edited for the last time by H.E. Spiegel, continues the objective of expanding the intellectual horizon of clinical chemistry. The fields of analytical, anatomical, sub-cellular and molecular sciences are all represented in this volume. * Detailed reviews by practicing scientists * Covers a broad range of clinical chemistry on a theoretical and practical basis * Includes easy to read chapters combining science and perspectives in a changing scientific landscape.
|
505 |
0 |
|
|a Cover; Copyright Page; Contents; Contributors; Publisher's Note; Preface; Chapter 1. Clinical Applications of Cytokine Assays; 1. Cytokines: An Overview; 2. Cytokines and Diseases; 3. Cytokine Assays; 4. Clinical Application of Cytokine Assays; 5. Conclusions; References; Chapter 2. Current Concepts on Diagnosis and Treatment of Acute Pancreatitis; 1. Introduction; 2. Pathophysiology of Acute Pancreatitis; 3. Diagnosis of Acute Pancreatitis; 4. Therapy; 5. Conclusions; References; Chapter 3. Mitochondrial DNA Mutations and Oxidative Stress in Mitochondrial Diseases; 1. Introduction
|
505 |
8 |
|
|a 2. A Brief Review of Studies on Mitochondrial Diseases3. The Genetic Map and Structural Characteristics of Human Mitochondrial DNA.; 4. Transmission by Maternal Inheritance and Random Segregation of mtDNA during Mitosis and Development; 5. Susceptibility of mtDNA to Oxidative Damage and Mutation; 6. Classification of Disease-Associated mtDNA Mutations; 7. Molecular Consequences of mtDNA Mutations; 8. Biochemical Basis for How mtDNA Mutations Cause Mitochondrial Dysfunction; 9. Oxidative Stress and Oxidative Damage Elicited by mtDNA Mutations
|
505 |
8 |
|
|a 10. Mitochondrial Diseases Caused by Mutations in Nuclear DNA11. Cybrids for Studies of Mitochondrial Diseases: Applications and Limitations; 12. Effect of mtDNA Mutations on the Apoptosis of Human Cells; 13. Therapy for Mitochondrial Diseases.; 14. Concluding Remarks; References; Chapter 4. Autoantibodies to dsDNA, Ro/SSA, and La/SSB in Systemic Lupus Erythematosus; 1. Introduction; 2. Basic Studies of Autoantibodies to dsDNA, Ro/SSA, and La/SSB; 3. Clinical Aspects of Anti-dsDNA, Anti-Ro/SSA, and Anti-La/SSB Autoantibodies; 4. Discussion and Conclusion; References
|
505 |
8 |
|
|a Chapter 5. Pathobiochemistry of Nephrotic Syndrome1. Introduction; 2. Structure and Function of the Glomerular Capillary Wall; 3. Pathogenesis of Proteinuria in Acquired Forms of Nephrotic Syndrome; 4. Biochemical Signs and Clinical Symptoms of Nephrotic Syndrome; 5. Diagnosis of Nephrotic Syndrome; 6. Treatment of Nephrotic Syndrome; 7. Summary; References; Chapter 6. Total Antioxidant Capacity; 1. Introduction; 2. Methodology; 3. What Determines Total Antioxidant Capacity?; 4. Total Antioxidant Capacity of Body Fluids; 5. Total Antioxidant Capacity of Tissue Homogenates
|
505 |
8 |
|
|a 6. Total Antioxidant Capacity of Food and Beverages7. Total Antioxidant Capacity of Plants; 8. Antioxidant Activity of Individual Compounds; 9. Effect of Nutrition on Total Antioxidant Activity of Body Fluids; 10. Effect of Physical Exercise on Blood Plasma Total Antioxidant Capacity; 11. Alterations in Total Antioxidant Capacity of Body Fluids and Tissue Homogenates in Diseases and Therapy; 12. Points of Concern; 13. Conclusions; References; Chapter 7. Lymphoid Malignancies: Immunophenotypic Analysis; 1. Introduction: Immunophenotypic Analysis; 2. Background: Immunophenotypic Analysis
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Clinical chemistry.
|
650 |
|
0 |
|a Biochemistry.
|
650 |
|
2 |
|a Chemistry, Clinical
|0 (DNLM)D002624
|
650 |
|
2 |
|a Biochemistry
|0 (DNLM)D001671
|
650 |
|
6 |
|a Chimie clinique.
|0 (CaQQLa)201-0016714
|
650 |
|
6 |
|a Biochimie.
|0 (CaQQLa)201-0001077
|
650 |
|
7 |
|a biochemistry.
|2 aat
|0 (CStmoGRI)aat300054538
|
650 |
|
7 |
|a Biochemistry
|2 fast
|0 (OCoLC)fst00831961
|
650 |
|
7 |
|a Clinical chemistry
|2 fast
|0 (OCoLC)fst00864330
|
700 |
1 |
|
|a Spiegel, Herbert E.
|
776 |
0 |
8 |
|i Print version:
|t Advances in clinical chemistry. Volume 37.
|d Amsterdam : Academic Press, 2003
|w (DLC) 58012341
|
830 |
|
0 |
|a Advances in Clinical Chemistry.
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120103379
|z Texto completo
|